Dasotraline Completed Phase 2 Trials for Adult Attention Deficit Hyperactivity Disorder (ADHD) Treatment

Back to Dasotraline
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01692782Adult Attention Deficit Hyperactivity Disorder